Form 4 for MRNA Moderna
Accepted 2026-06-08 16:34:20 ET · period of report 2026-06-04 · accession 0001682852-26-000119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-08 16:34 | 2026-06-04+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $30.96 | +15.3K | 79.3K | +24% | +$472.7K |
| DT | 2026-06-08 16:34 | 2026-06-04 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $50.00 | -3,471 | 67.5K | -5% | -$173.6K |
| DT | 2026-06-08 16:34 | 2026-06-05 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $51.59 | -5,705 | 73.6K | -7% | -$294.3K |
| DMT | 2026-06-08 16:34 | 2026-06-04+ | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -15.3K | 118.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-04 | M | A | 3,471 | $30.96 | 70,939 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. |
| 2 | Common | Common Stock | 2026-06-04 | S | D | 3,471 | $50.00 | 67,468 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. |
| 3 | Common | Common Stock | 2026-06-05 | M | A | 11,798 | — | 79,266 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2026-06-05 | F | D | 5,705 | $51.59 | 73,561 | D | — | — | (F3) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-06-04 | M | D | 3,471 | $0.00 | 38,187 | D | $30.96 · 2026-03-01 to 2035-03-01 | 3,471 Common Stock | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. (F4) 25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2026-06-05 | M | D | 11,798 | $0.00 | 117,976 | D | — · — to — | 11,798 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F2) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F5) 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. |